Development and validation of a nomogram predicting one-year mortality in patients undergoing percutaneous coronary

Jing-Jing Song1, Yu-Peng Liu2, Wen-Yao Wang3

  • 1Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Insights

This study developed a nomogram to predict one-year mortality risk in Asian patients after percutaneous coronary intervention (PCI). The tool helps clinicians assess patient risk for better decision-making.

Area of Science:

  • Cardiology
  • Medical Statistics

Background:

  • Percutaneous coronary intervention (PCI) is a common procedure for coronary artery disease.
  • Accurate prediction of post-PCI mortality is crucial for patient management.
  • Existing risk stratification tools may not be optimized for Asian populations.

Purpose of the Study:

  • To develop and validate a nomogram for predicting one-year all-cause mortality risk in Asian patients undergoing PCI.
  • To provide a tool for clinicians to make risk-dependent treatment decisions.

Main Methods:

  • A large-scale cohort of 9603 patients undergoing PCI in China was analyzed.
  • Least absolute shrinkage and selection operator (LASSO) Cox regression and backward stepwise regression were used to identify risk factors.
  • A nomogram was constructed using selected predictors and validated internally.

Main Results:

  • Six variables were identified: age, renal insufficiency, cardiac dysfunction, previous cerebrovascular disease, previous PCI, and TIMI 0-1 flow.
  • The nomogram demonstrated good predictive performance with an Area Under the Curve (AUC) of 0.792 in the derivation cohort and 0.754 in the validation cohort.
  • The nomogram effectively stratified patients into low-, intermediate-, and high-risk groups.

Conclusions:

  • A simple, validated nomogram for predicting one-year mortality after PCI in Asian patients was developed.
  • This tool can assist clinicians in making informed, risk-stratified decisions for patients undergoing PCI.
Abstract

Related Concept Videos